Literature DB >> 9043007

The effect of tramadol on dento-alveolar surgical pain.

M Collins1, I Young, P Sweeney, G C Fenn, M E Stratford, A Wilson, M Harris.   

Abstract

The aim of the study was to assess the analgesic effect of tramadol in the relief of pain after dentoalveolar operations that involve the removal of bone and suturing. Four-hundred and fifty-two patients over the age of 18 years who were to undergo removal of impacted teeth (n = 362), removal of root (n = 79), or alveolectomy, enucleation of cysts, or removal of soft tissue (n = 11) under local anesthesia were studied. Patients were randomly allocated to receive tramadol 100 mg or 50 mg four times daily, or 50 mg twice daily, or placebo. Median pain scores on the day of operation in the three tramadol groups were similar (2 in each group, ranges 1-5, 1-4.8, and 1-5 respectively) and were all significantly lower than that in the placebo group (2.3 range 1-4.2). The median number of Paracetamol tablets taken by patients in the three tramadol groups was 2 (ranges 0-8, 0-12 and 0-8 respectively), and were all significantly less than in the placebo group (4, range 0-12). More patients given tramadol reported complete pain relief than the placebo group. The advantages of tramadol continued over the next 2 days. There were no serious or unexpected adverse effects. It is concluded that tramadol is an effective analgesic after dentoalveolar operations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9043007     DOI: 10.1016/s0266-4356(97)90012-7

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  10 in total

1.  An evaluation of analgesic efficacy and clinical acceptability of intravenous tramadol as an adjunct to propofol sedation for third molar surgery.

Authors:  E A Shipton; J A Roelofse; R J Blignaut
Journal:  Anesth Prog       Date:  2003

2.  Effect of a simple dose-escalation schedule on tramadol tolerability : assessment in the clinical setting.

Authors:  I Tagarro; J Herrera; C Barutell; M C Díez; M Marín; D Samper; C Busquet; M J Rodríguez
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

3.  Safety of adjunct pre-emptive intravenous tramadol with midazolam sedation for third molar surgery.

Authors:  Lars B Eriksson; Åke Tegelberg
Journal:  Oral Maxillofac Surg       Date:  2015-04-30

4.  Analgesic efficacy and clinical acceptability of adjunct pre-emptive intravenous tramadol in midazolam sedation for third molar surgery.

Authors:  Lars Eriksson; Ake Tegelberg
Journal:  Oral Maxillofac Surg       Date:  2012-09-13

Review 5.  Pain management today - what have we learned?

Authors:  Richard M Langford
Journal:  Clin Rheumatol       Date:  2006-06-02       Impact factor: 2.980

Review 6.  Revisiting Tramadol: A Multi-Modal Agent for Pain Management.

Authors:  Ahmed Barakat
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

7.  Comparative evaluation of pre-emptive analgesic efficacy of intramuscular ketorolac versus tramadol following third molar surgery.

Authors:  Ashwin V Shah; K V Arun Kumar; Kirthi Kumar Rai; B P Rajesh Kumar
Journal:  J Maxillofac Oral Surg       Date:  2012-09-23

8.  Effect of submucosal application of tramadol on postoperative pain after third molar surgery.

Authors:  Onur Gönül; Tülin Satılmış; Ferit Bayram; Gökhan Göçmen; Aysegül Sipahi; Kamil Göker
Journal:  Head Face Med       Date:  2015-10-14       Impact factor: 2.151

9.  Comparison of the analgesic efficacy of oral ketorolac versus intramuscular tramadol after third molar surgery: A parallel, double-blind, randomized, placebo-controlled clinical trial.

Authors:  M-A Isiordia-Espinoza; A Pozos-Guillen; R Martinez-Rider; J Perez-Urizar
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-09-01

10.  Comparison of effect of intra socket ketamine and tramadol on postoperative pain after mandibular third molar surgery.

Authors:  Ashutosh Avinash Deshpande; O R Hemavathy; Sneha Krishnan; Rezin Ahmed
Journal:  Natl J Maxillofac Surg       Date:  2022-04-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.